XTL Biopharmaceutica (Israel) Price History
| XTLB Stock | ILS 9.00 0.00 0.00% |
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. As of today, the current price of XTL Biopharmaceutica stands at 9.00, as last reported on the 23rd of April, with the highest price reaching 9.60 and the lowest price hitting 9.00 during the day. XTL Biopharmaceutica is dangerous given 3 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.15, which attests that the company had a 0.15% return per unit of standard deviation over the last 3 months. We were able to interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 3.29% are justified by taking the suggested risk. Use XTL Biopharmaceuticals Downside Deviation of 6.36, mean deviation of 8.23, and Risk Adjusted Performance of 0.0927 to evaluate company specific risk that cannot be diversified away.
XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
XTL |
Sharpe Ratio = 0.1518
| Best Portfolio | Best Equity | |||
| Good Returns | XTLB | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 21.67 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.29 actual daily | 64 64% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average XTL Biopharmaceutica is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding it to a well-diversified portfolio.
XTL Biopharmaceutica Stock Price History Chart
There are several ways to analyze XTL Stock price data. The simplest method is using a basic XTL candlestick price chart, which shows XTL Biopharmaceutica price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 25, 2024 | 13.0 |
| Lowest Price | January 25, 2024 | 3.2 |
XTL Biopharmaceutica April 23, 2024 Stock Price Synopsis
Various analyses of XTL Biopharmaceutica's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell XTL Stock. It can be used to describe the percentage change in the price of XTL Biopharmaceutica from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of XTL Stock.| XTL Biopharmaceutica Price Action Indicator | (0.30) | |
| XTL Biopharmaceutica Price Rate Of Daily Change | 1.00 |
XTL Biopharmaceutica April 23, 2024 Stock Price Analysis
XTL Stock Price History Data
The price series of XTL Biopharmaceutica for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 9.8 with a coefficient of variation of 57.77. The daily prices for the period are distributed with arithmetic mean of 5.35. The median price for the last 90 days is 3.6.| Open | High | Low | Close | Volume | ||
04/23/2024 | 9.00 | 9.60 | 9.00 | 9.00 | ||
| 04/18/2024 | 9.00 | 9.60 | 9.00 | 9.00 | 3,829,643 | |
| 04/17/2024 | 9.60 | 9.70 | 8.90 | 9.10 | 2,797,223 | |
| 04/16/2024 | 10.00 | 10.30 | 9.10 | 9.40 | 8,248,550 | |
| 04/15/2024 | 9.90 | 11.20 | 9.80 | 10.00 | 11,653,027 | |
| 04/11/2024 | 10.20 | 10.20 | 9.30 | 9.30 | 8,502,140 | |
| 04/10/2024 | 11.20 | 11.20 | 10.30 | 10.30 | 5,139,075 | |
| 04/09/2024 | 11.00 | 12.00 | 11.00 | 11.10 | 16,300,701 | |
| 04/08/2024 | 11.30 | 11.60 | 11.10 | 11.20 | 4,366,952 | |
| 04/04/2024 | 11.90 | 12.10 | 10.90 | 11.30 | 15,459,576 | |
| 04/03/2024 | 10.20 | 11.40 | 10.00 | 11.20 | 6,136,078 | |
| 04/02/2024 | 11.00 | 11.20 | 10.00 | 10.10 | 8,768,941 | |
| 04/01/2024 | 10.10 | 10.90 | 9.60 | 10.70 | 12,784,332 | |
| 03/28/2024 | 10.10 | 10.50 | 9.70 | 9.90 | 19,654,377 | |
| 03/27/2024 | 11.60 | 12.00 | 10.10 | 10.70 | 27,520,788 | |
| 03/26/2024 | 11.50 | 13.50 | 10.90 | 11.60 | 35,925,509 | |
| 03/25/2024 | 9.50 | 17.10 | 9.20 | 13.00 | 77,909,555 | |
| 03/21/2024 | 8.90 | 9.70 | 7.50 | 7.50 | 105,188,296 | |
| 03/20/2024 | 4.00 | 9.20 | 4.00 | 8.90 | 24,496,974 | |
| 03/19/2024 | 4.10 | 4.20 | 3.90 | 3.90 | 479,425 | |
| 03/18/2024 | 4.00 | 4.20 | 3.80 | 3.90 | 895,194 | |
| 03/14/2024 | 3.40 | 3.40 | 3.40 | 3.40 | 90,000 | |
| 03/13/2024 | 3.30 | 3.30 | 3.30 | 3.30 | 200,000 | |
| 03/12/2024 | 3.30 | 3.40 | 3.30 | 3.40 | 51,229 | |
| 03/11/2024 | 3.40 | 3.40 | 3.30 | 3.30 | 118,000 | |
| 03/07/2024 | 3.30 | 3.50 | 3.30 | 3.40 | 920,799 | |
| 03/06/2024 | 3.40 | 3.40 | 3.40 | 3.40 | 1.00 | |
| 03/05/2024 | 3.50 | 3.50 | 3.40 | 3.50 | 15,000 | |
| 03/04/2024 | 3.50 | 3.50 | 3.40 | 3.50 | 1,000.00 | |
| 02/29/2024 | 3.30 | 3.50 | 3.30 | 3.30 | 670,995 | |
| 02/28/2024 | 3.30 | 3.40 | 3.30 | 3.30 | 53,800 | |
| 02/26/2024 | 3.40 | 3.40 | 3.40 | 3.40 | 350,000 | |
| 02/22/2024 | 3.50 | 3.50 | 3.40 | 3.50 | 524,920 | |
| 02/21/2024 | 3.60 | 3.60 | 3.30 | 3.30 | 383,700 | |
| 02/20/2024 | 3.50 | 3.50 | 3.50 | 3.50 | 134,000 | |
| 02/19/2024 | 3.60 | 3.60 | 3.40 | 3.40 | 53,435 | |
| 02/15/2024 | 3.50 | 3.60 | 3.40 | 3.60 | 123,027 | |
| 02/14/2024 | 3.60 | 3.60 | 3.40 | 3.50 | 58,856 | |
| 02/13/2024 | 3.50 | 3.70 | 3.50 | 3.60 | 242,000 | |
| 02/12/2024 | 3.50 | 3.70 | 3.30 | 3.70 | 128,000 | |
| 02/08/2024 | 3.60 | 3.60 | 3.50 | 3.60 | 242,000 | |
| 02/07/2024 | 3.60 | 3.60 | 3.50 | 3.60 | 14,000 | |
| 02/06/2024 | 3.50 | 3.60 | 3.50 | 3.60 | 41,000 | |
| 02/05/2024 | 3.60 | 3.70 | 3.30 | 3.30 | 874,100 | |
| 02/01/2024 | 3.50 | 3.60 | 3.40 | 3.50 | 462,734 | |
| 01/31/2024 | 3.50 | 3.50 | 3.50 | 3.50 | 1.00 | |
| 01/30/2024 | 3.50 | 3.50 | 3.50 | 3.50 | 1.00 | |
| 01/29/2024 | 3.50 | 3.60 | 3.40 | 3.50 | 164,300 | |
| 01/25/2024 | 3.60 | 3.70 | 3.10 | 3.20 | 1,161,807 | |
| 01/24/2024 | 3.60 | 3.60 | 3.40 | 3.60 | 88,000 | |
| 01/23/2024 | 3.60 | 3.60 | 3.50 | 3.60 | 29,000 | |
| 01/22/2024 | 3.60 | 3.60 | 3.40 | 3.40 | 45,435 | |
| 01/18/2024 | 3.60 | 3.60 | 3.50 | 3.60 | 14,000 | |
| 01/17/2024 | 3.60 | 3.60 | 3.40 | 3.50 | 202,029 | |
| 01/16/2024 | 3.60 | 3.60 | 3.40 | 3.60 | 14,000 | |
| 01/15/2024 | 3.50 | 3.60 | 3.40 | 3.40 | 26,618 | |
| 01/11/2024 | 3.60 | 3.70 | 3.30 | 3.70 | 360,111 | |
| 01/10/2024 | 3.80 | 3.80 | 3.70 | 3.80 | 14,000 | |
| 01/09/2024 | 3.60 | 3.70 | 3.60 | 3.60 | 20,099 | |
| 01/08/2024 | 3.80 | 3.80 | 3.70 | 3.70 | 27,200 | |
| 01/04/2024 | 3.60 | 3.80 | 3.50 | 3.80 | 942,221 |
About XTL Biopharmaceutica Stock history
XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel.
XTL Biopharmaceutica Stock Technical Analysis
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
XTL Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0927 | |||
| Jensen Alpha | 2.14 | |||
| Total Risk Alpha | 0.1081 | |||
| Sortino Ratio | 0.3897 | |||
| Treynor Ratio | 0.4795 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |